Darbepoetin alfa for anemia in patients with low or intermediate-1 risk myelodysplastic syndromes and positive predictive factors of response
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Fecha de publicación
2011Título de revista
CURRENT MEDICAL RESEARCH AND OPINION
Tipo de contenido
Artigo
![](/xmlui/themes/Mirage2//images/final_lines.png)